Moreover, studies conducted using the triple-negative breast cancer cell line MDA-MB-231 [3,28,31,33,36,37,39,47,52,53,54,56,59,61,63,67,73,74] and human breast cancer cell lineage expressing the Her2 SK-BR-3 gene [63,80] were also assessed. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.